Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by MBOI, N
Right arrow Articles by MOESLICHAN, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MBOI, N
Right arrow Articles by MOESLICHAN, S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1981 Oxford University Press

research-article

Estimate of the Risk of Post Transfusion Hepatitis B in Jakarta, Indonesia

N MBOI*, J GOLSON**, P B MCGREEVY{dagger}, R TAN{dagger}{dagger} and S MOESLICHAN§

*Jakarta Blood Donor Centre Jakarta, Indonesia
**US Naval Medical Research Unit No. 2, Jakarta Detachment, APO San Francisco 96356
{dagger}US Naval Medical Research Unit No. 2, Jakarta Detachment APO San Francisco 96356
{dagger}{dagger}US Naval Medical Research Unit No. 2, Jakarta Detachment, APO San Francisco 96356 USA
§Department of Child Health, Dr Cipto Mangun-kusumo Hospital Jakarta, Indonesia

Present address: Yale Arbovirus Research Unit, 60 College Street, New Haven, CT, 06510, USA.

Mboi N [Jakarta Blood Donor Centre, Jakarta, Indonesia], Olson JG, McGreevy PB, Tan R and Moeslichan S. An estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia. International Journal of Epidemiology 1981, 10: 367–372.

The prevalences of hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs) were determined in blood donors and transfusion recipients in Jakarta, Indonesia. In blood donors the prevalence of HBsAg was 10% while anti-HBs was 43%. In transfusion recipients the prevalence of HBsAg and anti-HBs was 67%. The prevalence of susceptible recipients or those without detectable HBsAg or anti-HBs was 33%. Thus, the probability that a susceptible recipient would receive HBsAg from a blood donor was calculated at 3.3%. Published data from other studies were used to estimate the risk of clinical post transfusion hepatitis in Jakarta at between 0% and 2%.

Received 19 May 1981


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.